Teva Reports First Quarter 2017 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/31/2026
- Wall Street ends lower after Fed Chair Warsh reaffirms inflation fight
- Fed chair Warsh kicks off Jackson Hole keynote address
- PayPal tumbles as Advent, Stripe said to drop $50 bln pursuit
- Oil settles lower on clues about Fed policy, rumors of Hormuz deal
- Dollar jumps after Warsh comments, set for weekly gain
- McKesson reports cybersecurity incident affecting its information systems
- Mizuho is bullish on Broadcom ahead of Sept. 2 earnings, citing 30-quarter streak
- Wall Street ends lower after Fed Chair Warsh reaffirms inflation fight
- BioNTech ends colorectal cancer mRNA therapy trial early
- Needham sees mature node semiconductor strength in latest tracker
Teva Pharma (TEVA) Reports In-Line Q1 EPS, Reaffirms Outlook
May 11, 2017 7:03 AM EDTTeva Pharma (NYSE: TEVA) reported Q1 EPS of $1.06, in-line with the analyst estimate of $1.06. Revenue for the quarter came in at $5.6 billion versus the consensus estimate of $5.7 billion.
Dr. Peterburg continued, Looking forward to the rest of 2017, we are reaffirming our full-year... More
